Nanomedicine

Illustration depicting MPsomes nanoparticles that compete with macrophages for adhesion to inflamed blood vessels in a tumor, thus altering the tumor microenvironment and inhibiting cancer progression.

Drug-free nanoparticles halted aggressive breast cancer tumors in preclinical trial

  • One response
New nanoparticles developed at the Technion do not release a drug, but rather affect the immune system around the tumor. In a preclinical trial, they inhibited aggressive triple-negative breast cancer.
Science website logo
SEARCH